-
effectivehealthcare-admin.ahrq.gov/about/epc-25-years
April 01, 2023 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … EHC en Español
EHC FAQs
Home
About EHC
25 Years … Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … to inform efforts in the years ahead. … https://effectivehealthcare.ahrq.gov/about/epc-25-years
Back to Top
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/please-help-find-something-to-ease-my-mothers-pain-with-restless-leg-syndrome-it-has-bothered-her-for-over-30-years-and-now-is-almost-unbearable-at-78-years-old-it-has-really-diminished-her-joy-in-life
November 01, 2017 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … It has bothered her for over 30 years and now is almost unbearable at 78 years old. … It has bothered her for over 30 years and now is almost unbearable at 78 years old. … It has bothered her for over 30 years and now is almost unbearable at 78 years old. … It has bothered her for over 30 years and now is almost unbearable at 78 years old.
-
effectivehealthcare-admin.ahrq.gov/products/get-involved/25th-anniversary-brochure
November 01, 2022 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … Home
Evidence Reports
Supporting Better Healthcare for 25 Years … SHARE:
Supporting Better Healthcare for 25 Years … This brochure, "AHRQ's EPC Program: Supporting Better Healthcare for 25 Years," shares information about … Internet Citation:
Brochure:
Supporting Better Healthcare for 25 Years
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/this-survey-would-about-early-warning-signs-of-multiple-sclerosis-which-i-documented-as-late-as-2-years-before-my-diagnosis-and-early-as-childhood-i-am-almost-finished-with-a-survey-i-spent-10-years-as-education-director-for
November 01, 2017 - I spent 10 years as Education Director for Kaiser-… … I spent 10 years as Education Director for Kaiser-…
Briefly describe a specific … This survey would about early warning signs of multiple sclerosis which I documented as late as 2 years … I also worked in health care over 30 years and was diagnosed with MS in 2005. … I spent 10 years as Education Director for Kaiser-…. Content last reviewed November 2017.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/25th-anniversary-epc-brochure.pdf
November 01, 2022 - AHRQ’s EPC Program: Supporting Better Healthcare for 25 Years
AHRQ’s Evidence-based Practice Center … March 2022, AHRQ summarized primary care research gaps identified in evidence
reviews from the last 3 years … 2022) Draft
report coming spring 2023
AHRQ’s EPC Program:
Supporting Better Healthcare
for 25 Years
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/population-children-18-years-of-age-1-what-are-the-incidences-and-prevalences-of-non-inflammatory-pain-syndromes-eg-benign-hypermobility-syndrome-patellofemoral-stress-syndrome-fibromyalgia-and-growing-pain-in-children-and-a
November 01, 2017 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … SHARE:
Population: Children < 18 years … Population: Children < 18 years of age:
What are the incidences and prevalences of non-inflammatory … the diagnostic accuracy of antinuclear antibody (ANA) and rheumatoid factor (RF) for children < 18 years … https://effectivehealthcare.ahrq.gov/get-involved/nominated-topics/population-children-18-years-of-age
-
effectivehealthcare-admin.ahrq.gov/products/dcis-endocrine-therapy/research
December 01, 2019 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … Note : This report is greater than 5 years old. … Use of endocrine therapy declined in the five years following diagnosis for both DCIS and early invasive … Current NCCN guidelines recommend that physicians consider tamoxifen treatment for five years for patients … , we sought to quantify the use of tamoxifen and AIs in 2007 and 2008 among older women within five years
-
effectivehealthcare-admin.ahrq.gov/products/asthma-pharmacologic-treatment/research-2017
September 01, 2019 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … Key Messages
In children less than 5 years old with recurrent wheezing, intermittent use of inhaled … Data in patients 4 to 11 years old suggest lower risk of exacerbations with ICS and LABA controller and … In patients 12 years and older with uncontrolled, persistent asthma, LAMA versus placebo as add-on to … LAMA is effective in the management of uncontrolled, persistent asthma in patients 12 years of age and
-
effectivehealthcare-admin.ahrq.gov/products/adhd-heart-disease-children/research
November 01, 2017 - Note : This report is greater than 5 years old. … Findings
During 844,615 person-years of follow-up, 1357 cases of MI and 296 cases of SCD occurred. … We had 113,324 person years of current use (average 0.74 years per user), with a crude incidence of MI … of 1.34 per 1000 person-years and of SCD of 0.30 per 1000. … or 45-64 years during follow- up.
-
effectivehealthcare-admin.ahrq.gov/products/depression-harms/research
May 01, 2020 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … assess adverse events of antidepressants in the treatment of major depressive disorder in adults 65 years … Key Messages In people 65 years of age or older: Serotonin norepinephrine reuptake inhibitors (SNRIs) … adverse events of antidepressants in the treatment of major depressive disorder (MDD) in adults 65 years … In patients 65 years of age or older, treatment of the acute phase of MDD with SNRIs (duloxetine and
-
effectivehealthcare-admin.ahrq.gov/products/cad-women-treatment/research
December 01, 2019 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … Page Contents
Archived : This report is greater than 3 years … Evidence, however, suggested a small benefit of initial conservative management at 5 years (2 studies … Given the small suggested benefit at 5 years, the wide confidence interval crossing 1, and the trend … Five studies assessed modifiers of effectiveness in women due to demographic factors (≥65 or ≥80 years
-
effectivehealthcare-admin.ahrq.gov/products/partial-breast-irradiation/research
May 01, 2023 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … WBI, intraoperative radiotherapy (IORT) was associated with a higher IBR rate at 5, 10, and over 10 years … (moderate to high SOE); IMRT showed no difference in IBR or overall survival at 5 and 10 years (low … Compared with WBI, IORT was associated with a higher IBR rate at 5, 10, and over 10 years (high SOE), … WBI Outcome Years Findings Findings/SOE Effect Direction Studies Patients SOE Ipsilateral Breast
-
effectivehealthcare-admin.ahrq.gov/products/pqmp/protocol
August 01, 2024 - (at 5, 6, 8 and 10 years), and adolescence (at 12 and 15 years). … -17 years, and 18-21 years). … ) Middle Childhood (5 years to 10 years) Adolescence (11 years to 21 years) Vision Screening Perform … of 11-14 years, 15-17 years, 18-21 years) Screen with audiometry including 6,000 and 8,000 Hz high frequencies … once between 11 and 14 years.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-e-1_0.xlsx
January 01, 2020 - February 2012 to March 2013 Adult Cardiac arrest Physician
Paramedic Yes ETI Ground Included: age ≥18 years … Excluded: patients with penetrating STBI, those retrieved from other hospitals, and those below 18 years … : 23.5%
5-9 years: 26.3%
10-14 years: 29.4%
≥ 15 years: 16.8% NR NR High
Cudnik, 2010 2010 0 0 0 ETI … : 959 (1.7)
6-10 years: 183 (0.3)
11-17 years: 606 (1.1)
18-30 years: 3666 (6.4)
31-50 years: 9192 (16.1 … )
51-70 years: 21,518 (37.6)
>70 years: 19,529 (34.1)
Unknown: 1556 (2.7) Race:
White: 69.5%
Black:
-
effectivehealthcare-admin.ahrq.gov/products/hypertension-drugs-utilization/research
December 01, 2019 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … Note : This report is greater than 5 years old. … During 1976–1980, only 51 percent of hypertensive patients ages 18–74 years were aware of their hypertension … Hypertension control rates have been shown to be the lowest among individuals age 60 years and above, … despite the availability of public/government-provided health insurance for those age 65 years and older
-
effectivehealthcare-admin.ahrq.gov/products/adhd-update/systematic-review-2018
February 01, 2021 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … Evidence was insufficient on imaging or electroencephalogram to diagnose ADHD in children 7–17 years … Cognitive behavioral therapy may improve ADHD symptoms among children 7–17 years of age. … than the Cambridge Neuropsychological Test Automated Battery for the diagnosis of ADHD for ages 7–17 years … The 2011 AHRQ systematic review highlighted the benefit of psychostimulants for children 6–12 years of
-
effectivehealthcare-admin.ahrq.gov/products/weight-gain-prevention/research
December 01, 2019 - Registry of Patient Registries
Former Projects and Initiatives
Annual Reports
25 Years … Archived : This report is greater than 3 years old. … The timepoints of interest for weight outcomes were: 1 year, 2 years, 5 years, and the last reported … timepoint after 5 years.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
March 01, 2025 - • No eligible studies evaluated children aged less than 18 years. … • No eligible studies evaluated children aged less than 18 years. … The median followup was 10.7 years, ranging from 1 to 32 years. … The median followup was 10.7 years, ranging from
1–32 years. … The median followup was 10.0 years, ranging from 16 weeks to 20 years.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - • Continuing bisphosphonates after 3–5 years
versus discontinuation reduces some measures of
vertebral … Mean
participant age was 72 years, with all but two
studies reporting mean age <80 years. … for 2 years, and intermediately increased in women
assigned denosumab for 2 years, placebo for 1 year … Safety assessment
of raloxifene over eight years in a clinical trial setting. … Ten years’
experience with alendronate for osteoporosis in
postmenopausal women.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
September 01, 2020 - Association (AUA) reviews.3-5 We included controlled studies
of CLPC (stages T1–T3a) treatments ≥5 years … WW probably results in
small to large increases in metastases through 15–20 years. … and late genitourinary toxicity over 3 years. … After 10 years, overall and prostate-cancer
mortality were similar across all three treatments though … For most men
with CLPC including those with life expectancies of 15–20 years, evidence indicates that